FTIOP
BIIB icon

Fiduciary Trust International of Pennsylvania’s Biogen BIIB Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-586
Closed -$207K – 314
2018
Q3 		$207K Buy
+586
New +$202K 0.01% 339
2016
Q2 		– Sell
-1,109
Closed -$289K – 302
2016
Q1 		$289K Buy
+1,109
New +$293K 0.02% 256

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's BIIB Position: Q4 2018 in Review

Fiduciary Trust International of Pennsylvania sold out of Biogen (BIIB) in Q4 2018, closing a stake of 586 shares — an estimated $207K sold.

Fiduciary Trust International of Pennsylvania first reported a position in BIIB in Q1 2016 and held it in 2 quarters. The position peaked at $289K in Q1 2016. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Fiduciary Trust International of Pennsylvania reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 586 Biogen shares in Q4 2018, an estimated $207K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Biogen in Q1 2016 and held it in 2 quarters.
  • Fiduciary Trust International of Pennsylvania's Biogen position peaked at $289K in Q1 2016.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2018, filed 14 Jan 2019.